Form 4: Dynavax Technologies VP of Finance Acquires 20,000 Stock Options

Justin Burgess, VP of Finance & CAO of Dynavax Technologies, reports the acquisition of 20,000 stock options.

Summary

• On March 16, 2024, Justin Burgess, VP of Finance & CAO at Dynavax Technologies Corp, acquired 20,000 stock options.
• The exercise price of these options is $11.70.
• The options vest over three years, with one-third vesting after twelve months and the remainder vesting monthly thereafter.
• The expiration date for these options is March 16, 2031.
• Following this transaction, Burgess directly owns 20,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. The acquisition of stock options by an executive is generally viewed as a positive, but it's a routine event.

Positives

• The acquisition of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of stock options by a company executive can have a minor positive impact on shareholder sentiment.

Key Dates